Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

C-reactive protein and future cardiovascular events in statin-treated patients with angina pectoris: the extended TRUTH study.

Nozue T, Fukui K, Yamamoto S, Kunishima T, Umezawa S, Onishi Y, Tohyama S, Takeyama Y, Morino Y, Yamauchi T, Hibi K, Sozu T, Terashima M, Michishita I; TRUTH Investigators.

J Atheroscler Thromb. 2013;20(9):717-25. Epub 2013 Jun 8.

2.

Reverse vessel remodeling but not coronary plaque regression could predict future cardiovascular events in ACS patients with intensive statin therapy--the extended JAPAN-ACS study.

Miyauchi K, Daida H, Morimoto T, Hiro T, Kimura T, Nakagawa Y, Yamagishi M, Ozaki Y, Kadota K, Kimura K, Hirayama A, Kimura K, Hasegawa Y, Uchiyama S, Matsuzaki M; JAPAN-ACS Investigators.

Circ J. 2012;76(4):825-32.

3.

Comparison of change in coronary atherosclerosis in patients with stable versus unstable angina pectoris receiving statin therapy (from the Treatment With Statin on Atheroma Regression Evaluated by Intravascular Ultrasound With Virtual Histology [TRUTH] study).

Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima M, Michishita I; TRUTH Investigators.

Am J Cardiol. 2013 Apr 1;111(7):923-9. doi: 10.1016/j.amjcard.2012.12.008. Epub 2013 Jan 18.

PMID:
23337838
4.

Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy.

Koskinas KC, Zaugg S, Yamaji K, García-García HM, Taniwaki M, Klingenberg R, Moschovitis A, Lüscher TF, van Tits LJ, Matter CM, Windecker S, Räber L.

Atherosclerosis. 2016 Apr;247:154-60. doi: 10.1016/j.atherosclerosis.2016.02.015. Epub 2016 Feb 16.

PMID:
26921743
5.

Impacts of estimated glomerular filtration rate on coronary atherosclerosis and plaque composition before and during statin therapy in patients with normal to mild renal dysfunction: subanalysis of the TRUTH study.

Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Hibi K, Terashima M, Michishita I; TRUTH INVESTIGATORS.

Nephrology (Carlton). 2012 Sep;17(7):628-35. doi: 10.1111/j.1440-1797.2012.01628.x.

PMID:
22708952
6.

Time course of statin-induced changes in coronary atherosclerosis using intravascular ultrasound with virtual histology.

Nozue T, Fukui K, Yamamoto S, Kunishima T, Umezawa S, Onishi Y, Tohyama S, Hibi K, Sozu T, Terashima M, Michishita I; TRUTH Investigators.

Coron Artery Dis. 2013 Sep;24(6):481-6. doi: 10.1097/MCA.0b013e32836325ac.

PMID:
23751736
7.

Treatment with statin on atheroma regression evaluated by intravascular ultrasound with Virtual Histology (TRUTH Study): rationale and design.

Nozue T, Yamamoto S, Tohyama S, Umezawa S, Kunishima T, Sato A, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Sozu T, Michishita I; Kanagawa PTCA Conference Study Group.

Circ J. 2009 Feb;73(2):352-5. Epub 2008 Dec 26.

8.

Statin treatment for coronary artery plaque composition based on intravascular ultrasound radiofrequency data analysis.

Nozue T, Yamamoto S, Tohyama S, Umezawa S, Kunishima T, Sato A, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Sozu T, Terashima M, Michishita I.

Am Heart J. 2012 Feb;163(2):191-9.e1. doi: 10.1016/j.ahj.2011.11.004.

PMID:
22305836
9.

High-sensitivity C-reactive protein and plaque composition in patients with stable angina pectoris: a virtual histology intravascular ultrasound study.

Kubo T, Matsuo Y, Hayashi Y, Yamano T, Tanimoto T, Ino Y, Kitabata H, Takarada S, Hirata K, Tanaka A, Nakamura N, Mizukoshi M, Imanishi T, Akasaka T.

Coron Artery Dis. 2009 Dec;20(8):531-5. doi: 10.1097/MCA.0b013e328332a6b0.

PMID:
19855269
10.

Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound.

Nasu K, Tsuchikane E, Katoh O, Tanaka N, Kimura M, Ehara M, Kinoshita Y, Matsubara T, Matsuo H, Asakura K, Asakura Y, Terashima M, Takayama T, Honye J, Hirayama A, Saito S, Suzuki T.

JACC Cardiovasc Interv. 2009 Jul;2(7):689-96. doi: 10.1016/j.jcin.2009.04.016.

11.

Prognostic impact of plaque echolucency in combination with inflammatory biomarkers on cardiovascular outcomes of coronary artery disease patients receiving optimal medical therapy.

Ishizu T, Seo Y, Machino T, Kawamura R, Kimura T, Murakoshi N, Sato A, Takeyasu N, Watanabe S, Aonuma K.

Atherosclerosis. 2011 May;216(1):120-4. doi: 10.1016/j.atherosclerosis.2011.01.048. Epub 2011 Feb 25.

PMID:
21353222
12.

Efficacy of Statin Therapy in Inducing Coronary Plaque Regression in Patients with Low Baseline Cholesterol Levels.

Wakabayashi K, Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Miyake S, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima M, Suzuki H, Michishita I; TRUTH investigators.

J Atheroscler Thromb. 2016 Sep 1;23(9):1055-66. doi: 10.5551/jat.34660. Epub 2016 Mar 31.

13.

Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial.

Hibi K, Kimura T, Kimura K, Morimoto T, Hiro T, Miyauchi K, Nakagawa Y, Yamagishi M, Ozaki Y, Saito S, Yamaguchi T, Daida H, Matsuzaki M; JAPAN-ACS Investigators.

Atherosclerosis. 2011 Dec;219(2):743-9. doi: 10.1016/j.atherosclerosis.2011.08.024. Epub 2011 Aug 22.

PMID:
21899843
14.

Impact of baseline plaque components on plaque progression in nonintervened coronary segments in patients with angina pectoris on rosuvastatin 10 mg/day.

Hong YJ, Jeong MH, Choi YH, Ma EH, Ko JS, Lee MG, Park KH, Sim DS, Yoon NS, Youn HJ, Kim KH, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC.

Am J Cardiol. 2010 Nov 1;106(9):1241-7. doi: 10.1016/j.amjcard.2010.06.046. Epub 2010 Sep 9.

PMID:
21029819
15.

Relation of C-reactive protein to coronary plaque characteristics on grayscale, radiofrequency intravascular ultrasound, and cardiovascular outcome in patients with acute coronary syndrome or stable angina pectoris (from the ATHEROREMO-IVUS study).

Cheng JM, Oemrawsingh RM, Garcia-Garcia HM, Akkerhuis KM, Kardys I, de Boer SP, Langstraat JS, Regar E, van Geuns RJ, Serruys PW, Boersma E.

Am J Cardiol. 2014 Nov 15;114(10):1497-503. doi: 10.1016/j.amjcard.2014.08.013. Epub 2014 Aug 27.

PMID:
25248815
16.

HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.

Tani S, Nagao K, Hirayama A.

Am J Cardiovasc Drugs. 2011 Dec 1;11(6):411-7. doi: 10.2165/11594620-000000000-00000.

PMID:
22149320
17.

Low serum docosahexaenoic acid is associated with progression of coronary atherosclerosis in statin-treated patients with diabetes mellitus: results of the treatment with statin on atheroma regression evaluated by intravascular ultrasound with virtual histology (TRUTH) study.

Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima M, Michishita I.

Cardiovasc Diabetol. 2014 Jan 13;13:13. doi: 10.1186/1475-2840-13-13.

18.

C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy.

Puri R, Nissen SE, Libby P, Shao M, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Raichlen JS, Uno K, Kataoka Y, Nicholls SJ.

Circulation. 2013 Nov 26;128(22):2395-403. doi: 10.1161/CIRCULATIONAHA.113.004243. Epub 2013 Sep 16.

19.

Comparison of the effects of pitavastatin versus pravastatin on coronary artery plaque phenotype assessed by tissue characterization using serial virtual histology intravascular ultrasound.

Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima M, Michishita I.

Heart Vessels. 2015 Jan;30(1):36-44. doi: 10.1007/s00380-013-0453-8. Epub 2013 Dec 15.

PMID:
24337500
20.

Effect of pitavastatin treatment on changes of plaque volume and composition according to the reduction of high-sensitivity C-reactive protein levels.

Hong YJ, Jeong MH, Ahn Y, Kim SW, Bae JH, Hur SH, Ahn TH, Rha SW, Kim KS, Chae IH, Kim JH, Yun KH, Oh SK; LAMIS investigators.

J Cardiol. 2012 Oct;60(4):277-82. doi: 10.1016/j.jjcc.2012.04.003. Epub 2012 Jun 1.

Supplemental Content

Support Center